Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Diabetes and Vascular Disease Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Varo, N.
Right arrow Articles by Schönbeck, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varo, N.
Right arrow Articles by Schönbeck, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products

Nerea Varo

Area of Cardiovascular Pathophysiology, Center for Applied Medical Research, University of Navarra School of Medicine, Pamplona, Spain

Peter Libby

Donald W. Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, US

Rebecca Nuzzo

Donald W. Reynolds Cardiovascular Clinical Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, US

Joseph Italiano

Division of Hematology, Brigham and Women's Hospital, Boston, US

Alessandro Doria

Section on Genetics and Epidemiology, Joslin Diabetes Center, Boston, US

Uwe Schönbeck

Cardiovascular Disease, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Room 7542, Ridgefield, CT 10877, US

The pro-inflammatory CD40/CD40L dyad participates in atherogenesis. Plasma levels of the soluble ligand (sCD40L) predict cardiovascular events and are elevated in diabetic patients. This study compared CD40/CD40L surface expression on platelets and T lymphocytes of diabetic and control subjects, and tested whether glucose and advanced glycation end products (AGEs) stimulate sCD40L release.

Constitutive and inducible surface expression of CD40/CD40L on platelets or T lymphocytes did not differ between diabetic patients (n=9) and controls (n=13). Platelets from diabetic patients contained higher intracellular CD40L than controls (p<0.05) and thrombin stimulated greater platelet sCD40L release in diabetic patients (15.11 ± 16.77 ng/ml) compared to controls (3.64 ± 2.03 ng/ml; p<0.05). Glucose and AGEs induced platelet sCD40L release and CD40L expression in mouse megakaryocytes.

This study demonstrates elevated CD40L content and inducible release from platelets of diabetic patients, and identifies glucose and AGEs as potential triggers of expression and release accounting for the elevated sCD40L plasma levels in these patients.

Key Words: CD40 ligand • inflammation • diabetes • platelets

Diabetes and Vascular Disease Research, Vol. 2, No. 2, 81-87 (2005)
DOI: 10.3132/dvdr.2005.014


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. Antoniades, C. Bakogiannis, D. Tousoulis, A. S. Antonopoulos, and C. Stefanadis
The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
J. Am. Coll. Cardiol., August 18, 2009; 54(8): 669 - 677.
[Abstract] [Full Text] [PDF]